May 18, 2017 -
The College of Healthcare Information Management Executives’ has named four finalists in its $1 million National Patient ID Challenge, aimed at developing a solution that ensures 100 percent accuracy of patient’s health data to reduce preventable medical errors, according to a report by Health Data Management.
Correctly identifying patients continues to be a top challenge for healthcare organizations, with cases of misidentification negatively affecting patient care.
“The time is now to solve this problem,” said Liz Johnson, chair of CHIME’s board of trustees and chief information officer for acute care hospitals and applied clinical informatics at Tenet Healthcare. “Our patients deserve better and the CHIME Healthcare Innovation Trust National Patient ID Challenge has presented the industry with a great opportunity to address this serious patient safety issue in our healthcare system. We know that a workable solution exists, and we are thrilled to announce that four worthy solutions will proceed to the prototype testing round.”
A panel of independent judges selected four challenge finalists to advance to the prototype testing round.
Michael Braithwaite, founder and CEO of biometrics development vendor Personavera, developed a solution that identifies patients through the use of multiple biometric technologies.
Bon Sy, a computer scientists and electrical engineer with a focus in biometrics security and privacy, developed a solution that identifies patients based on a combination of behavioral and biometric information.
Team HarmonIQ Health System, a workflow and analytics solutions vendor, submitted a solution that leverages blockchain, public ledger, FHIR and encryption and hashing technologies to identify patients.
Finally, RightPatient’s solution taps into photos, biometric third-party and other data, to enable patient identification.
The prototype testing stage of CHIME’s challenge has two distinct phases: enrollment and identification, as well as privacy and security. Ultimately a winner will be announced by CHIME in November.
CHIME has partnered with medical device manufacturing firm Modulus for the prototype testing phase of the challenge.
The company says it has significant experience in designing and manufacturing Class II and Class III medical devices.